Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Expert recommendations on the psychological needs of patients with rheumatoid arthritis.

Leon L, Redondo M, Fernández-Nebro A, Gómez S, Loza E, Montoro M, Garcia-Vicuña R, Galindo M.

Rheumatol Int. 2018 May 28. doi: 10.1007/s00296-018-4057-6. [Epub ahead of print]

PMID:
29808295
2.

Vasoactive intestinal peptide gene polymorphisms, associated with its serum levels, predict treatment requirements in early rheumatoid arthritis.

Seoane IV, Martínez C, García-Vicuña R, Ortiz AM, Juarranz Y, Talayero VC, González-Álvaro I, Gomariz RP, Lamana A.

Sci Rep. 2018 Feb 1;8(1):2035. doi: 10.1038/s41598-018-20400-6.

3.

REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients.

González-Álvaro I, Blasco AJ, Lázaro P, Sánchez-Piedra C, Almodovar R, Bachiller-Corral J, Balsa A, Caliz R, Candelas G, Fernández-Carballido C, García-Aparicio A, García-Magallón B, García-Vicuña R, Gómez-Centeno A, Ortiz AM, Sanmartí R, Sanz J, Tejera B.

Heliyon. 2017 Nov 14;3(11):e00452. doi: 10.1016/j.heliyon.2017.e00452. eCollection 2017 Nov.

4.

Prevalence of Comorbidities in Rheumatoid Arthritis and Evaluation of Their Monitoring in Clinical Practice: The Spanish Cohort of the COMORA Study.

Balsa A, Lojo-Oliveira L, Alperi-López M, García-Manrique M, Ordóñez-Cañizares C, Pérez L, Ruiz-Esquide V, Corrales A, Narváez J, Rey-Rey J, Rodríguez-Lozano C, Ojeda S, Muñoz-Fernández S, Nolla JM, García-Torrón J, Gamero F, García-Vicuña R, Hernández-Cruz B, Campos J, Rosas J, García-Llorente JF, Gómez-Centeno A, Cáliz R, Sanmartí R, Bermúdez A, Abasolo-Alcázar L, Fernández-Nebro A, Rodríguez-Rodríguez L, Marras C, González-Gay MÁ, Hmamouchi I, Martín-Mola E.

Reumatol Clin. 2017 Jul 12. pii: S1699-258X(17)30134-1. doi: 10.1016/j.reuma.2017.06.002. [Epub ahead of print] English, Spanish.

6.

Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients.

Llorente I, Merino L, Ortiz AM, Escolano E, González-Ortega S, García-Vicuña R, García-Vadillo JA, Castañeda S, González-Álvaro I.

Rheumatol Int. 2017 May;37(5):799-806. doi: 10.1007/s00296-017-3674-9. Epub 2017 Feb 27.

7.

Barriers to and facilitators of implementing quality standards in Hospital Day Care Units in Rheumatology: Qualitative approach to the VALORA study.

Martín Martínez MA, Zaragoza Gaynor GA, Martínez Fernández C, Gobbo Montoya M, García-Vicuña R; en representación del Comité Científico del proyecto VALORA.

Reumatol Clin. 2018 Jul - Aug;14(4):196-201. doi: 10.1016/j.reuma.2016.12.004. Epub 2017 Jan 30. English, Spanish.

8.

Recommendations by the Spanish Society of Rheumatology for the management of patients diagnosed with rheumatoid arthritis who cannot be treated with methotrexate.

García-Vicuña R, Martín-Martínez MA, Gonzalez-Crespo MR, Tornero-Molina J, Fernández-Nebro A, Blanco-García FJ, Blanco-Alonso R, Marsal-Barril S; en representación del Comité Científico del trabajo de Recomendaciones de la Sociedad Española de Reumatología para el manejo clínico del paciente con artritis reumatoide que no puede utilizar metotrexato.

Reumatol Clin. 2017 May - Jun;13(3):127-138. doi: 10.1016/j.reuma.2016.10.002. Epub 2016 Nov 5. English, Spanish.

9.

Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity.

Sala-Icardo L, Lamana A, Ortiz AM, García Lorenzo E, Moreno Fresneda P, García-Vicuña R, González-Álvaro I.

Reumatol Clin. 2017 Nov - Dec;13(6):318-325. doi: 10.1016/j.reuma.2016.08.006. Epub 2016 Oct 15. English, Spanish.

10.

Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases.

Vinicki JP, García-Vicuña R, Arredondo M, López-Bote JP, García-Vadillo JA, Castañeda S, Álvaro-Gracia JM.

Reumatol Clin. 2017 Jul - Aug;13(4):210-213. doi: 10.1016/j.reuma.2016.06.003. Epub 2016 Aug 4. English, Spanish.

11.

Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review.

Martin-Mola E, Balsa A, García-Vicuna R, Gómez-Reino J, González-Gay MA, Sanmartí R, Loza E.

Rheumatol Int. 2016 Aug;36(8):1043-63. doi: 10.1007/s00296-016-3506-3. Epub 2016 Jun 6. Review.

PMID:
27271502
12.

Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial.

Álvaro-Gracia JM, Jover JA, García-Vicuña R, Carreño L, Alonso A, Marsal S, Blanco F, Martínez-Taboada VM, Taylor P, Martín-Martín C, DelaRosa O, Tagarro I, Díaz-González F.

Ann Rheum Dis. 2017 Jan;76(1):196-202. doi: 10.1136/annrheumdis-2015-208918. Epub 2016 Jun 7.

PMID:
27269294
13.

Variability in Rheumatology day care hospitals in Spain: VALORA study.

Hernández Miguel MV, Martín Martínez MA, Corominas H, Sanchez-Piedra C, Sanmartí R, Fernandez Martinez C, García-Vicuña R; en representación del Comité Científico del proyecto VALORA.

Reumatol Clin. 2017 Jan - Feb;13(1):10-16. doi: 10.1016/j.reuma.2016.01.007. Epub 2016 Mar 9. English, Spanish.

14.

Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity.

Seoane IV, Ortiz AM, Piris L, Lamana A, Juarranz Y, García-Vicuña R, González-Álvaro I, Gomariz RP, Martínez C.

PLoS One. 2016 Feb 16;11(2):e0149141. doi: 10.1371/journal.pone.0149141. eCollection 2016.

15.

Quality standards for rheumatology outpatient clinic. The EXTRELLA project.

Nolla JM, Martínez C, García-Vicuña R, Seoane-Mato D, Rosario Lozano MP, Alonso A, Alperi M, Barbazán C, Calvo J, Delgado C, Fernández-Nebro A, Mateo L, Pérez Sandoval T, Pérez Venegas J, Rodríguez Lozano C, Rosas J; Grupo de Trabajo del Proyecto EXTRELLA.

Reumatol Clin. 2016 Sep-Oct;12(5):248-55. doi: 10.1016/j.reuma.2015.11.004. Epub 2016 Jan 14. English, Spanish.

16.

The Minor Allele of rs7574865 in the STAT4 Gene Is Associated with Increased mRNA and Protein Expression.

Lamana A, López-Santalla M, Castillo-González R, Ortiz AM, Martín J, García-Vicuña R, González-Álvaro I.

PLoS One. 2015 Nov 16;10(11):e0142683. doi: 10.1371/journal.pone.0142683. eCollection 2015.

17.

[Rheumatoid arthritis at present].

González-Álvaro I, García-Vicuña R.

Med Clin (Barc). 2016 Feb 5;146(3):112-4. doi: 10.1016/j.medcli.2015.06.004. Epub 2015 Jul 27. Spanish. No abstract available.

PMID:
26228258
18.

[Two-year incidence of new immune-mediated inflammatory diseases in patients with inflammatory bowel disease: A study in the AQUILES cohort].

Marín-Jiménez I, Gisbert JP, Pérez-Calle JL, García-Sánchez V, Tabernero S, García-Vicuña R, Romero C, Juliá B, Vanaclocha F, Cea-Calvo L; Investigadores del estudio AQUILES.

Gastroenterol Hepatol. 2015 Dec;38(10):569-74. doi: 10.1016/j.gastrohep.2015.04.003. Epub 2015 May 14. Spanish.

PMID:
25983283
19.

Efficiency of adalimumab, etanercept and infliximab in ankylosing spondylitis in clinical practice.

Escudero-Vilaplana V, Ramírez-Herráiz E, Alañón-Plaza E, Trovato-López N, García-Vicuña R, Carreño-Pérez L, Morell-Baladrón A, Sanjurjo-Sáez M.

Int J Clin Pharm. 2015 Oct;37(5):808-14. doi: 10.1007/s11096-015-0124-1. Epub 2015 Apr 25.

PMID:
25910480
20.

Patterns of use and dosing of tocilizumab in the treatment of patients with rheumatoid arthritis in routine clinical practice: the ACT-LIFE study.

Balsa A, Tovar Beltrán JV, Cáliz Cáliz R, Mateo Bernardo I, García-Vicuña R, Rodríguez-Gómez M, Belmonte Serrano MA, Marras C, Loza Cortina E, Pérez-Pampin E, Vila V.

Rheumatol Int. 2015 Sep;35(9):1525-34. doi: 10.1007/s00296-015-3237-x. Epub 2015 Mar 13.

PMID:
25773655

Supplemental Content

Loading ...
Support Center